We next sought to determine the contribution of immune tolerogenic microenvironment in DLBCL by means of Foxp3, IL-10 and PD-1 expression, which has been demonstrated to play a role in immune response failure in cHL33. The gene discussed is IL10; the disease is diffuse large B-cell lymphoma.